RAQQS is an international management company and was founded in 2010. From our offices in India we support our client portfolio throughout Europe, North-America, Middle East and Asia. We use only the tools that make the most sense for each situation. 

RAQQS has developed an upfront diagnostic X-ray that enables companies to identify and focus on only the process changes that will quickly make the biggest differences, ensuring faster results with smaller initial investment. 

RAQQS approach starts with a full potential diagnostic and embeds methodology with added efficiency and speed from lean. In each case, we first gain an understanding a company's value stream, and then move rapidly to mapping out processes and costs. Next, we define a view of "full potential" through such measures as bottleneck analysis and internal and external bench marking. Finally, we target areas for improvement, unleashing the trained teams.  

Our experience across industries and geographies allows us to perform diagnostics quickly that help companies achieve sustainable improvements. Using the cash and capabilities assessment to focus on areas with the most potential for generating results, 

Our clients avoid the extra cost and time of training and deploying more teams than absolutely required. We partner with the right suite of third-party companies to deliver the right tools and solutions that best meet our clients' needs. In our experience, we find that complexity—in its many forms—slows innovation.

Among the typical complexity pain points our clients experience: too many R&D projects that are not fully aligned with company or product strategy, too many processes—processes that may not be consistently followed or are not delivering what wins in the market, too many decision makers without a single point of accountability, and too many sites, capabilities and design methodologies without a clear understanding of what drives competitive advantage. 

We work closely with our clients to untangle their complexity and install a clear and concise, repeatable R&D formula. Specifically, we enable them to innovate rapidly and spend more wisely by helping them to: